QA Testing

download/print PDF version
reload without photo
PharmLabs San Diego Certificate of Analysis
Sample Kryptonite .5g Syringe
Delta9 THC 45.10% Total THC (THC + THCa) 45.10%
Logo_coa
Sample ID  130327-004 (569) Matrix   Concentrate (Inhalable Cannabis Good)
Tested for  Golden Organic Goods
Sampled   - Received   Mar 27, 2013 Reported   Sep 20, 2013
Analyses executed   CAN+

CAN+ - Cannabinoids

 |  Instrument HPLC-VWD  | Method SOP-001
The expanded Uncertainty of the Cannabinoid analysis is approximately ±7.806% at the 95% Confidence Level
Analyte   LOD
mg/g
LOQ
mg/g
Result
%
Result
mg/g
Cannabidivarin (CBDV)   0.039 0.16 NT NT
Cannabidiolic Acid (CBDA)   0.001 0.16 NT NT
Cannabigerol Acid (CBGA)   0.001 0.16 NT NT
Cannabigerol (CBG)   0.001 0.16 NT NT
Cannabidiol (CBD)   0.001 0.16 0.50 5.00
Tetrahydrocannabivarin (THCV)   0.001 0.16 NT NT
Cannabinol (CBN)   0.001 0.16 1.70 17.00
Tetrahydrocannabinol (Δ9-THC)   0.003 0.16 45.10 451.00
Δ8-tetrahydrocannabinol (Δ8-THC)   0.004 0.16 NT NT
Cannabicyclol (CBL)   0.002 0.16 NT NT
Cannabichromene (CBC)   0.002 0.16 NT NT
Tetrahydrocannabinolic Acid (THCA)   0.001 0.16 NT NT
Total THC ( THCa * 0.877 + Δ9THC )       45.10 451.00
Total Cannabinoids Analyzed       47.30 473.00